Bergenin (Synonyms: Cuscutin)

Name: Bergenin
Brand: MedChemExpress
SKU: HY-N0017
Rating: 5.0 (6 reviews)

Cat. No.: HY-N0017 Purity: 99.34%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

Bergenin is a cytoprotective and antioxidative polyphenol found in many medicinal plants. Bergenin has a wide spectrum activities such as hepatoprotective, antiinflammatory, immunomodulatory, antitumor, antiviral, and antifungal properties.

For research use only. We do not sell to patients.

CAS No. : 477-90-7

Size	Stock	Quantity

Free Sample (0.1 - 0.2 mg)	Apply Now
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	In-stock	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	In-stock	Estimated Time of Arrival: December 31
Solid
2 mg	In-stock	Estimated Time of Arrival: December 31
5 mg	In-stock	Estimated Time of Arrival: December 31
10 mg	In-stock	Estimated Time of Arrival: December 31
25 mg	In-stock	Estimated Time of Arrival: December 31
50 mg	In-stock	Estimated Time of Arrival: December 31
100 mg	Get quote
200 mg	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 6 publication(s) in Google Scholar

Other Forms of Bergenin:

Bergenin (Standard) Get quote

6 Publications Citing Use of MCE Bergenin

RT-PCR

Apoptosis Analysis

In Vivo Efficacy Study

: Bergenin purchased from MedChemExpress. Usage Cited in: J Transl Med. 2024 Oct 17;22(1):946. [Abstract]; Measurement of HIF-1α mRNA expression levels teated with Bergenin (20 μM).

: Bergenin purchased from MedChemExpress. Usage Cited in: J Transl Med. 2024 Oct 17;22(1):946. [Abstract]; Measurement of HIF-1α protein expression levels teated with Bergenin (20 μM).

: Bergenin purchased from MedChemExpress. Usage Cited in: J Transl Med. 2024 Oct 17;22(1):946. [Abstract]; Treatment with either Bergenin (20 μM) or NAC resulted in a decrease in Hemin-induced apoptosis.

: Bergenin purchased from MedChemExpress. Usage Cited in: J Transl Med. 2024 Oct 17;22(1):946. [Abstract]; JC-1 show that 3D biological scaffold encapsulation of Bergenin (20 μM) or NAC treatment can reduce the apoptosis rate induced by Hemin treatment.

: Bergenin purchased from MedChemExpress. Usage Cited in: J Transl Med. 2024 Oct 17;22(1):946. [Abstract]; Representative images of hemorrhagic lesions results in rats treated with Bergenin (0.5 μL/kg).

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All NF-κB Isoform Specific Products:

View All Isoforms

NF-κB NF-κB1/p50 RelA/p65 RelB c-Rel

Biological Activity
Purity & Documentation
References
Customer Review

Description

Cellular Effect

Cell Line	Type	Value	Description	References
A549	IC₅₀	77.28 μM Compound: Bergenin	Antiproliferative activity against human A549 cells incubated for 48 to 72 hrs by MTT assay Antiproliferative activity against human A549 cells incubated for 48 to 72 hrs by MTT assay	[PMID: 28395218]
C8166	EC₅₀	40 μg/mL Compound: 6	Antiviral activity against HIV1 MN in human C8166 cells assessed as reduction of antigen gp120 production by ELISA Antiviral activity against HIV1 MN in human C8166 cells assessed as reduction of antigen gp120 production by ELISA	[PMID: 8786362]
HepG2	IC₅₀	34.56 μM Compound: Bergenin	Antiproliferative activity against human HepG2 cells incubated for 48 to 72 hrs by MTT assay Antiproliferative activity against human HepG2 cells incubated for 48 to 72 hrs by MTT assay	[PMID: 28395218]
MCF7	IC₅₀	>100 μM Compound: Bergenin	Antiproliferative activity against human MCF7 cells incubated for 48 to 72 hrs by MTT assay Antiproliferative activity against human MCF7 cells incubated for 48 to 72 hrs by MTT assay	[PMID: 28395218]
Neutrophil	IC₅₀	303.12 μM Compound: 16	Antiinflammatory activity in human neutrophils assessed as inhibition of opsonized zymosan A-mediated superoxide anions production by WST-1 based respiratory burst assay Antiinflammatory activity in human neutrophils assessed as inhibition of opsonized zymosan A-mediated superoxide anions production by WST-1 based respiratory burst assay	[PMID: 22437110]
PC-3	IC₅₀	>100 μM Compound: Bergenin	Antiproliferative activity against human PC3 cells incubated for 48 to 72 hrs by MTT assay Antiproliferative activity against human PC3 cells incubated for 48 to 72 hrs by MTT assay	[PMID: 28395218]
SGC-7901	IC₅₀	23.56 μM Compound: Bergenin	Antiproliferative activity against human SGC7901 cells incubated for 48 to 72 hrs by MTT assay Antiproliferative activity against human SGC7901 cells incubated for 48 to 72 hrs by MTT assay	[PMID: 28395218]
THP-1	IC₅₀	0.208 μM Compound: 1	Inhibition of LPS-induced IL6 production in human THP1 cells after 24 hrs Inhibition of LPS-induced IL6 production in human THP1 cells after 24 hrs	[PMID: 25111439]
THP-1	IC₅₀	12.5 μM Compound: 1	Inhibition of LPS-induced TNFalpha production in human THP1 cells after 24 hrs Inhibition of LPS-induced TNFalpha production in human THP1 cells after 24 hrs	[PMID: 25111439]
THP-1	IC₅₀	130 μM Compound: 1	Cytotoxicity against human THP1 cells after 24 hrs by MTT assay Cytotoxicity against human THP1 cells after 24 hrs by MTT assay	[PMID: 25111439]
THP-1	IC₅₀	84 μM Compound: 1	Cytotoxicity against human THP1 cells after 48 hrs by MTT assay Cytotoxicity against human THP1 cells after 48 hrs by MTT assay	[PMID: 25111439]

In Vitro

Bergenin (7.5-30μM; 24 hours) decreases the viability of HeLa cervical cancer cells (IC₅₀=15 μM)^[1].
Bergenin (7.5-30 μM; 24 hours) induces apoptosis in HeLa cervical cancer cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:	HeLa cervical cancer cells
Concentration:	7.5, 15, 30 µM
Incubation Time:	24 hours
Result:	Decreased the viability of HeLa cervical cancer cells.

Cell Viability Assay^[1]

Cell Line:	HeLa cervical cancer cells
Concentration:	7.5, 15, 30 µM
Incubation Time:	24 hours
Result:	Induced apoptosis in HeLa cervical cancer cells.

In Vivo

Pretreatment with Bergenin (12.5-100 mg/kg; i.p.; once) produces a dose-related inhibition of acetic acid-induced writhing in mice^[3].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Male Swiss Webster C57BL/6 mice^[3]
Dosage:	12.5, 25, 50, 100 mg/kg
Administration:	i.p.; Once
Result:	Produced a dose-related inhibition of acetic acid-induced writhing in mice.

Molecular Weight

328.27

Formula

C₁₄H₁₆O₉

CAS No.

477-90-7

Appearance

Solid

Color

White to off-white

SMILES

OC1=C(OC)C(O)=C([C@@]2([H])[C@@](OC3=O)([H])[C@@H](O)[C@H](O)[C@@H](CO)O2)C3=C1

Structure Classification

Initial Source

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	2 years
	-20°C	1 year

Solvent & Solubility

In Vitro:

DMSO : 103.3 mg/mL (314.68 mM; Need ultrasonic and warming; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	3.0463 mL	15.2314 mL	30.4627 mL
5 mM	0.6093 mL	3.0463 mL	6.0925 mL
10 mM	0.3046 mL	1.5231 mL	3.0463 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (7.62 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (7.62 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (7.62 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

Purity & Documentation

Purity: 99.34%

Select Batch:

Data Sheet (282 KB) SDS (393 KB)

COA (255 KB) HNMR (155 KB) LCMS (93 KB)

Handling Instructions (2659 KB)

References

[1]. Shi X, et al. Anticancer activity of bergenin against cervical cancer cells involves apoptosis, cell cycle arrest, inhibition of cell migration and the STAT3 signalling pathway. Exp Ther Med. 2019 May;17(5):3525-3529. [Content Brief]

[2]. Yun J, et al. Bergenin decreases the morphine-induced physical dependence via antioxidative activity in mice. Arch Pharm Res. 2015 Jun;38(6):1248-54. [Content Brief]

[3]. de Oliveira CM, et al. Antinociceptive properties of bergenin. J Nat Prod. 2011 Oct 28;74(10):2062-8. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	3.0463 mL	15.2314 mL	30.4627 mL	76.1568 mL
	5 mM	0.6093 mL	3.0463 mL	6.0925 mL	15.2314 mL
	10 mM	0.3046 mL	1.5231 mL	3.0463 mL	7.6157 mL
	15 mM	0.2031 mL	1.0154 mL	2.0308 mL	5.0771 mL
	20 mM	0.1523 mL	0.7616 mL	1.5231 mL	3.8078 mL
	25 mM	0.1219 mL	0.6093 mL	1.2185 mL	3.0463 mL
	30 mM	0.1015 mL	0.5077 mL	1.0154 mL	2.5386 mL
	40 mM	0.0762 mL	0.3808 mL	0.7616 mL	1.9039 mL
	50 mM	0.0609 mL	0.3046 mL	0.6093 mL	1.5231 mL
	60 mM	0.0508 mL	0.2539 mL	0.5077 mL	1.2693 mL
	80 mM	0.0381 mL	0.1904 mL	0.3808 mL	0.9520 mL
	100 mM	0.0305 mL	0.1523 mL	0.3046 mL	0.7616 mL

Bergenin Related Classifications

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Bergenin477-90-7CuscutinNF-κBAutophagyApoptosisBacterialFungalVirus ProteaseNuclear factor-κBNuclear factor-kappaBInhibitorinhibitorinhibit

Your Recently Viewed Products:

Product Name

Requested Quantity *

Applicant Name *

Salutation

Email Address *

Phone Number *

Department

Organization Name *

City

State

Country or Region *

Remarks

Product Name

Lot #

Applicant Name *

Email Address *

Phone Number

Department *

Organization Name *

Country or Region *

Remarks

Name
Email *

	Sorry, but the email address you supplied was invalid.

Bergenin (Synonyms: Cuscutin)

Customer Review

Other Forms of Bergenin:

Bergenin Related Antibodies

6 Publications Citing Use of MCE Bergenin

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

View All NF-κB Isoform Specific Products:

Biological Activity

Purity & Documentation

References

Customer Review

Bergenin Related Antibodies

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Bergenin Related Classifications

Keywords:

Your Recently Viewed Products:

Customer Review

Request for HNMR Report

SAFETY DATA SHEET (SDS)

Request for HNMR Report